Quotient Limited

Greetings. Welcome to the Quotient Limited Third Quarter Fiscal Year 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero from your telephone keypad. Please note this conference is being recorded. I'll now turn the conference over to Peter Mueller, Chief Financial Officer. You may begin.

Thank you, Rob. Good morning everyone and welcome to Quotient's early conference call for our third quarter of fiscal year 2021. Joining me today is Franz Wald, Chief Executive Officer of Quotient. Today's conference call is being broadcast live through an audio webcast and the replay of the conference call will be available later today at www.quotientpd.com. During this call, quotients will be making forward-looking statements, including guidance and projections as to future operating results and expected development and commercialization timelines. Because such statements deal with future events, actual results may defer material from those projected in the forward-looking statements. Additional information concerning factors that could cause actual results to defer materially from those in the forward-looking statements can be found in quotients filed with the U.S. Securities and Exchange Commission as well as in this morning's release. The forward-looking statements, including guidance and projections provided during this call, are valid only as of today's date, and Quotient assumes no obligation to publicly update these forward-looking statements. With that, I would like to turn the call over to Quotient's Chief Executive Officer, Franz Wald.

Thanks, Peter, and good morning, everyone. Since our last earnings call in early November, The second wave of the global pandemic has adversely impacted business activities in Europe. Government travel restrictions and lockdowns imposed in response to the second wave seriously affected our operations in Europe and the UK. I'm happy to report that notwithstanding this environment, our reagent manufacturing operations in Edinburgh continue to function well as we continue to supply reagents to our customers.